Macrophage migration inhibitory factor (MIF) accounts for one of the first cytokine activities to have been described, and it has emerged recently to be an important regulator of innate and adaptive immunity. MIF is an upstream activator of monocytes/macrophages, and it is centrally involved in the pathogenesis of septic shock, arthritis, and other inflammatory conditions. The protein is encoded by a unique but highly conserved gene, and X-ray crystallography studies have shown MIF to define a new protein fold and structural superfamily. Although recent work has begun to illuminate the signal transduction pathways activated by MIF, the nature of its membrane receptor has not been known. Using expression cloning and functional analysis, we report herein that CD74, a Type II transmembrane protein, is a high-affinity binding protein for MIF. MIF binds to the extracellular domain of CD74, and CD74 is required for MIF-induced activation of the extracellular signal–regulated kinase–1/2 MAP kinase cascade, cell proliferation, and PGE2 production. A recombinant, soluble form of CD74 binds MIF with a dissociation constant of ∼9 × 10−9 Kd, as defined by surface plasmon resonance (BIAcore analysis), and soluble CD74 inhibits MIF-mediated extracellular signal–regulated kinase activation in defined cell systems. These data provide a molecular basis for MIF's interaction with target cells and identify it as a natural ligand for CD74, which has been implicated previously in signaling and accessory functions for immune cell activation.
Skip Nav Destination
Article navigation
2 June 2003
Article|
June 02 2003
MIF Signal Transduction Initiated by Binding to CD74
Lin Leng,
Lin Leng
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Search for other works by this author on:
Christine N. Metz,
Christine N. Metz
2The North-Shore–Long Island Jewish Research Institute, Manhasset, NY 11030
Search for other works by this author on:
Yan Fang,
Yan Fang
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Search for other works by this author on:
Jing Xu,
Jing Xu
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Search for other works by this author on:
Seamas Donnelly,
Seamas Donnelly
3Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland
Search for other works by this author on:
John Baugh,
John Baugh
3Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland
Search for other works by this author on:
Thomas Delohery,
Thomas Delohery
4Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10031
Search for other works by this author on:
Yibang Chen,
Yibang Chen
5Department of Pharmacology, Mount Sinai School of Medicine, New York, NY 10029
Search for other works by this author on:
Robert A. Mitchell,
Robert A. Mitchell
6J.G. Brown Cancer Center, University of Louisville, Louisville, KY 40202
Search for other works by this author on:
Richard Bucala
Richard Bucala
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Search for other works by this author on:
Lin Leng
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Christine N. Metz
2The North-Shore–Long Island Jewish Research Institute, Manhasset, NY 11030
Yan Fang
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Jing Xu
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Seamas Donnelly
3Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland
John Baugh
3Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland
Thomas Delohery
4Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10031
Yibang Chen
5Department of Pharmacology, Mount Sinai School of Medicine, New York, NY 10029
Robert A. Mitchell
6J.G. Brown Cancer Center, University of Louisville, Louisville, KY 40202
Richard Bucala
1Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520
Address correspondence to Richard Bucala, Dept. of Medicine, Section of Rheumatology, Yale University School of Medicine, 333 Cedar St., P.O. Box 208031, New Haven, CT 06520-8031. Phone: 203-737-1453; Fax: 203-785-7053; E-mail: [email protected]
*
Abbreviations used in this paper: Alexa-MIF, Alexa-488–modified MIF; ERK, extracellular signal–regulated kinase; MIF, macrophage migration inhibitory factor; sCD74, soluble CD74.
Received:
February 21 2003
Revision Received:
February 21 2003
Accepted:
March 27 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (11): 1467–1476.
Article history
Received:
February 21 2003
Revision Received:
February 21 2003
Accepted:
March 27 2003
Citation
Lin Leng, Christine N. Metz, Yan Fang, Jing Xu, Seamas Donnelly, John Baugh, Thomas Delohery, Yibang Chen, Robert A. Mitchell, Richard Bucala; MIF Signal Transduction Initiated by Binding to CD74 . J Exp Med 2 June 2003; 197 (11): 1467–1476. doi: https://doi.org/10.1084/jem.20030286
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement